524414 — Norris Medicines Share Price
0.000.00%
Last trade - 00:00- IN₹167.91m
- IN₹378.12m
- IN₹56.36m
- 20
- 10
- 69
- 21
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 68.27 | ||
| Price to Sales | 3.71 | ||
| EV to EBITDA | 250.02 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -9.09% | ||
| Return on Equity | n/a | ||
| Operating Margin | -8.38% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 78.44 | 122.51 | 94.38 | 83.59 | 56.36 | n/a | n/a | -19.1% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Norris Medicines Limited is an India-based company, which is focused on the health care industry. The Company is engaged in the manufacturing and exporting medicines and injections. The Company’s product categories include antibiotic, anti-inflammatory and analgesic range, G. I. range, dermatological range, nutrition range, anti-malaria, anti-emetic, cough/cold range, dental range, diabetics and cardiac, and miscellaneous range. Its antibiotic products include Arizon-100, Arizon-250, Arizon-500, Cefan-dry syurp, and Cefan DT-50. Its G.I. products include Denzym Syrup, Denzym Oral Drop, Ezynor-20, Regus-DSR, Sucrinor and Rinotac. Its dermatological products include Clobec-G, Gabax, Morfit Plus, Novadin-M, Silwon-C and Tioderm. Its nutrition products include Cand XP, Cand Fort, Can D suspension and Hemfit Plus Syrup. It has two plants situated at GIDC, Ankleshwar, Gujarat. Both the plants of the Company are World Health Organization Good Manufacturing Practices (WHO GMP) approved.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 7th, 1990
- Public Since
- December 15th, 1993
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 10,000,700
- Address
- Plot No. 801/P, ANKLESHWAR, 393002
- Web
- https://www.norrispharma.com/
- Phone
- +91 2646223462
- Auditors
- M/s. BAHEDIA & ASSOCIATES
Upcoming Events for 524414
Q1 2026 Norris Medicines Ltd Earnings Release
Similar to 524414
Aayush Wellness
Bombay Stock Exchange
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
FAQ
What is the Norris Medicines share price?
As of Today at 22:20 UTC, shares in Norris Medicines are trading at IN₹17.00. This share price information is delayed by 15 minutes.
How has the Norris Medicines share price performed this year?
Shares in Norris Medicines last closed at IN₹17.00 and the price had moved by +31.58% over the past 365 days. In terms of relative price strength the Norris Medicines share price has outperformed the S&P BSE 100 Index by +23.95% over the past year.
What are the analyst and broker recommendations for Norris Medicines?
There is no consensus recommendation for this security.
Find out moreWhat is the Norris Medicines dividend yield?
Norris Medicines does not currently pay a dividend.
Does Norris Medicines pay a dividend?
Norris Medicines does not currently pay a dividend.
When does Norris Medicines next pay dividends?
Norris Medicines does not currently pay a dividend.
How do I buy Norris Medicines shares?
To buy shares in Norris Medicines you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Norris Medicines?
As of the previous close price of IN₹17.00, shares in Norris Medicines had a market capitalisation of IN₹167.91m.
Where are Norris Medicines shares listed?
Here are the trading details for Norris Medicines:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 524414
What kind of share is Norris Medicines?
Based on an overall assessment of its quality, value and momentum Norris Medicines is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Norris Medicines share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Norris Medicines share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Norris Medicines. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +1.52%.
As of the last closing price of IN₹17.00, shares in Norris Medicines were trading -6.8% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Norris Medicines PE Ratio?
The Norris Medicines PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹17.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Norris Medicines?
We do not have data on Norris Medicines' directors